Search Results 211-220 of 37939 for Liver%2Bfailure
A Study of the Effectiveness and Safety of Subcutaneous Semaglutide for Patients with Fatty-Liver Disease, not Caused by Alcoholism · More about research at Mayo ...
... liver disease for investigations into the molecular pathogenesis of cirrhosis, liver cancer, and end-stage liver disease. A Study to Evaluate the ...
... liver disease, optimizing outcomes after liver transplantation, and expanding access to liver transplantation. Conditions treated · Alcoholic hepatitis ...
Torsemide is used to help treat fluid retention (edema) and swelling that is caused by congestive heart failure, liver disease, kidney disease. It belongs ...
Colonoscopy, Upper endoscopy, Cirrhosis, Acute liver failure, Hepatic encephalopathy, Portal hypertension, Fontan-assoc...iated liver disease. Show more ...
Mayo Clinic is developing a bioartificial liver to support patients with acute liver failure. The Mayo Spheroid Reservoir Bioartificial Liver has been shown ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
He not only survived severe liver failure by undergoing a liver transplant at Mayo Clinic, but he also overcame mucormycosis, a deadly fungal disease that ...
The ability to monitor disease progression in nonalcoholic fatty liver disease (NAFLD) and understand its impact on liver outcomes remains poorly understood ...
Aqel, M.D., is a gastroenterologist and transplant hepatologist with a focus in nonalcoholic fatty liver disease, viral hepatitis and hepatocellular carcinoma.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.